Cargando…
The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk
Background: The goal of the public procurement of pharmaceuticals is to purchase sufficient quantities of high-quality pharmaceuticals at cost-effective prices for a given population. This goal can be undercut if corruption infiltrates the procurement process. Good procurement practices can help mit...
Autores principales: | Kohler, Jillian Clare, Dimancesco, Deirdre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170361/ https://www.ncbi.nlm.nih.gov/pubmed/32194011 http://dx.doi.org/10.1080/16549716.2019.1694745 |
Ejemplares similares
-
Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review
por: Griffore, Kari A., et al.
Publicado: (2023) -
The Global Fund: why anti-corruption, transparency and accountability matter
por: Chang, Zhihao, et al.
Publicado: (2021) -
An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement
por: Mackey, Tim K., et al.
Publicado: (2020) -
Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations
por: Gorodensky, Ariel, et al.
Publicado: (2022) -
Increasing transparency and accountability in national pharmaceutical systems
por: Paschke, Anne, et al.
Publicado: (2018)